New hope for myeloma: experimental drug etentamig enters human trials
NCT ID NCT06892522
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug, etentamig, in people with multiple myeloma, a blood cancer. The drug is given alone or with other cancer medicines. The goal is to see if it is safe and works against the cancer. About 440 adults will take part at sites worldwide.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Etentamig (given alone or with lenalidomide, dexamethasone, daratumumab, or carfilzomib)
What this could lead to
If successful, this could provide a new treatment option for multiple myeloma, especially for patients whose cancer has returned or not responded to other therapies.
What could go wrong
This is an early-phase trial (phase 1/2), so safety and effectiveness are not yet proven. Side effects are possible, and the drug may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atrium Health Levine Cancer Institute /ID# 276193
RECRUITINGCharlotte, North Carolina, 28204-2990, United States
-
Atrium Health Wake Forest Baptist Medical Center /ID# 274847
RECRUITINGWinston-Salem, North Carolina, 27157, United States
-
Coffs Harbour Health Campus /ID# 272010
RECRUITINGCoffs Harbour, New South Wales, 2450, Australia
-
Colorado Blood Cancer Institute /ID# 273129
RECRUITINGDenver, Colorado, 80218, United States
-
Hadassah Medical Center-Hebrew University /ID# 271362
RECRUITINGJerusalem, 91120, Israel
-
Hammersmith Hospital /ID# 274615
RECRUITINGLondon, England, W12 0HS, United Kingdom
-
Icon Cancer Care - South Brisbane /ID# 271836
RECRUITINGSouth Brisbane, Queensland, 4101, Australia
-
Moffitt Cancer Center /ID# 272628
RECRUITINGTampa, Florida, 33612, United States
-
Nagoya City University Hospital /ID# 273529
RECRUITINGNagoya, Aichi-ken, 467-8602, Japan
-
Oncology Hematology Care - Kenwood /ID# 272918
RECRUITINGCincinnati, Ohio, 45236, United States
-
Peter MacCallum Cancer Centre /ID# 272024
RECRUITINGMelbourne, Victoria, 3000, Australia
-
Port Macquarie Base Hospital /ID# 275925
RECRUITINGPort Macquarie, New South Wales, 2444, Australia
-
Rabin Medical Center. /ID# 271365
RECRUITINGPetah Tikva, 4941492, Israel
-
Rambam Health Care Campus- Haifa /ID# 271364
RECRUITINGHaifa, 3525408, Israel
-
Royal Adelaide Hospital /ID# 272629
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Soroka Medical Center /ID# 271367
RECRUITINGBeersheba, Southern District, 8410101, Israel
-
St Vincent's Hospital - Melbourne /ID# 276451
RECRUITINGFitzroy, Victoria, 3065, Australia
-
The Chaim Sheba Medical Center /ID# 271366
RECRUITINGRamat Gan, Tel Aviv, 5265601, Israel
-
The Perth Blood Institute - West Perth /ID# 272469
RECRUITINGWest Perth, Western Australia, 6005, Australia
-
The University of Osaka Hospital /ID# 275791
RECRUITINGSuita-shi, Osaka, 565-0871, Japan
Contact Phone: •••-•••-••••
-
University Hospital Kyoto Prefectural University of Medicine /ID# 275713
RECRUITINGKyoto, Kyoto, 602-8566, Japan
-
University of North Carolina at Chapel Hill /ID# 274667
RECRUITINGChapel Hill, North Carolina, 27514, United States
-
Weill Cornell Medical College /ID# 272517
RECRUITINGNew York, New York, 10065, United States
-
Westmead Hospital /ID# 271880
RECRUITINGWestmead, New South Wales, 2145, Australia
-
Winship Cancer Institute of Emory University /ID# 274830
RECRUITINGAtlanta, Georgia, 30322, United States